improving Oncology exploration with built-in KRAS Assay providers and RAS Assays
In the promptly evolving area of oncology study, exact and successful mutation screening is important for acquiring focused therapies. The KRAS solutions System plays a pivotal purpose On this landscape by providing complete options for KRAS mutation profiling and Investigation. KRAS mutations, present in somewhere around 95% of RAS-similar oncogen